Surgery Partners ROA 2013-2025 | SGRY
Current and historical return on assets (ROA) values for Surgery Partners (SGRY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Surgery Partners ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $-0.17B | $7.95B | -2.18% |
| 2025-06-30 | $-0.18B | $7.96B | -2.32% |
| 2025-03-31 | $-0.20B | $7.95B | -2.53% |
| 2024-12-31 | $-0.17B | $7.89B | -2.26% |
| 2024-09-30 | $-0.06B | $7.53B | -0.84% |
| 2024-06-30 | $-0.03B | $7.49B | -0.48% |
| 2024-03-31 | $0.00B | $6.98B | 0.01% |
| 2023-12-31 | $-0.01B | $6.88B | -0.18% |
| 2023-09-30 | $-0.03B | $6.78B | -0.51% |
| 2023-06-30 | $-0.05B | $6.62B | -0.82% |
| 2023-03-31 | $-0.09B | $6.64B | -1.39% |
| 2022-12-31 | $-0.05B | $6.68B | -0.84% |
| 2022-09-30 | $-0.03B | $6.54B | -0.49% |
| 2022-06-30 | $-0.03B | $6.29B | -0.48% |
| 2022-03-31 | $-0.04B | $6.29B | -0.64% |
| 2021-12-31 | $-0.08B | $6.12B | -1.41% |
| 2021-09-30 | $-0.09B | $5.63B | -1.54% |
| 2021-06-30 | $-0.14B | $5.62B | -2.46% |
| 2021-03-31 | $-0.15B | $5.64B | -2.78% |
| 2020-12-31 | $-0.16B | $5.41B | -2.96% |
| 2020-09-30 | $-0.18B | $5.31B | -3.48% |
| 2020-06-30 | $-0.13B | $5.25B | -2.62% |
| 2020-03-31 | $-0.12B | $5.09B | -2.41% |
| 2019-12-31 | $-0.11B | $5.02B | -2.27% |
| 2019-09-30 | $-0.24B | $4.92B | -4.94% |
| 2019-06-30 | $-0.24B | $4.89B | -5.11% |
| 2019-03-31 | $-0.24B | $4.88B | -5.16% |
| 2018-12-31 | $-0.24B | $4.68B | -5.15% |
| 2018-09-30 | $-0.12B | $4.56B | -2.64% |
| 2018-06-30 | $-0.12B | $4.58B | -2.70% |
| 2018-03-31 | $-0.10B | $4.60B | -2.45% |
| 2017-12-31 | $-0.08B | $4.62B | -2.23% |
| 2017-09-30 | $-0.02B | $4.60B | -0.74% |
| 2017-06-30 | $0.01B | $2.67B | 0.34% |
| 2017-03-31 | $0.01B | $2.29B | 0.62% |
| 2016-12-31 | $0.01B | $2.31B | 0.45% |
| 2016-09-30 | $0.01B | $2.25B | 0.46% |
| 2016-06-30 | $0.01B | $2.21B | 0.43% |
| 2016-03-31 | $0.00B | $2.20B | 0.13% |
| 2015-12-31 | $0.00B | $2.10B | 0.20% |
| 2015-06-30 | $-0.02B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.088B | $3.114B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $165.999B | 30.48 |
| HCA Healthcare (HCA) | United States | $107.452B | 17.79 |
| CVS Health (CVS) | United States | $105.376B | 12.12 |
| Elevance Health (ELV) | United States | $82.464B | 12.09 |
| Cencora (COR) | United States | $68.573B | 22.11 |
| Natera (NTRA) | United States | $33.416B | 0.00 |
| DiDi Global (DIDIY) | China | $23.344B | 21.57 |
| Labcorp Holdings (LH) | United States | $22.106B | 16.86 |
| Medpace Holdings (MEDP) | United States | $16.564B | 41.12 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.437B | 0.00 |
| Viatris (VTRS) | United States | $15.215B | 5.67 |
| ICON (ICLR) | Ireland | $15.077B | 14.96 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| Solventum (SOLV) | United States | $13.687B | 13.28 |
| Revvity (RVTY) | United States | $13.234B | 24.37 |
| CochLear (CHEOY) | Australia | $12.390B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.808B | 20.82 |
| Avantor (AVTR) | United States | $8.045B | 12.29 |
| Sonic Healthcare (SKHHY) | Australia | $7.967B | 0.00 |
| HealthEquity (HQY) | United States | $7.186B | 26.87 |
| BrightSpring Health Services (BTSG) | United States | $7.149B | 42.62 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.054B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.014B | 39.49 |
| PACS (PACS) | United States | $5.477B | 33.30 |
| Sotera Health (SHC) | United States | $5.259B | 25.36 |
| Alignment Healthcare (ALHC) | United States | $4.764B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.930B | 51.45 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.537B | 2.67 |
| Progyny (PGNY) | United States | $2.174B | 42.75 |
| Establishment Labs Holdings (ESTA) | United States | $1.916B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.850B | 11.05 |
| Ardent Health (ARDT) | United States | $1.226B | 4.00 |
| Teladoc Health (TDOC) | United States | $1.123B | 0.00 |
| Nutex Health (NUTX) | United States | $1.105B | 8.45 |
| CareDx (CDNA) | United States | $1.050B | 17.16 |
| Omada Health (OMDA) | United States | $0.957B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.869B | 14.22 |
| InnovAge Holding (INNV) | United States | $0.791B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.688B | 0.00 |
| Embecta (EMBC) | United States | $0.648B | 3.68 |
| Sonida Senior Living (SNDA) | United States | $0.592B | 0.00 |
| Enhabit (EHAB) | United States | $0.546B | 24.52 |
| CryoPort (CYRX) | United States | $0.520B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.472B | 0.00 |
| SBC Medicals (SBC) | United States | $0.448B | 8.25 |
| Auna S.A (AUNA) | Luxembourg | $0.419B | 6.74 |
| Agilon Health (AGL) | United States | $0.411B | 0.00 |
| Oncology Institute (TOI) | United States | $0.328B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.320B | 67.24 |
| Shoulder Innovations (SI) | United States | $0.307B | 0.00 |
| So-Young (SY) | China | $0.291B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| KindlyMD (NAKA) | United States | $0.177B | 0.00 |
| LifeMD (LFMD) | United States | $0.172B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.135B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.125B | 0.00 |
| Biodesix (BDSX) | United States | $0.093B | 0.00 |
| DocGo (DCGO) | United States | $0.082B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.079B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.043B | 0.00 |
| Pomdoctor - (POM) | China | $0.029B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.41 |
| OSR Holdings (OSRH) | United States | $0.021B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |